News Releases

Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer

November 7, 2019

Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

November 5, 2019

Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board

October 28, 2019

Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek™ Prostate Cancer Study

October 25, 2019

Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019)

October 22, 2019

Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts

October 15, 2019

Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board

October 10, 2019

Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study

September 23, 2019

Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek™ Prostate Cancer Study

September 19, 2019

Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

September 16, 2019

1
2
3
4
Next »

Latest News & Events

Nov 7, 2019

Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer

Read More...

Nov 5, 2019

Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

Read More...

Oct 28, 2019

Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.